Get Premium to unlock powerful stock data
FRA:6GJ (USA)  
Glaukos Corp logo

Glaukos Corp

€ 43.20 (-4.85%) Jun 29
P/E:
At Loss
P/B:
3.58
Market Cap:
€ 2.06B ($ 2.15B)
Enterprise V:
€ 2.03B ($ 2.11B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
2.06B
Market Cap $:
2.15B
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value €:
2.03B
Enterprise Value $:
2.11B
PB Ratio:
3.58
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Glaukos Corp
NAICS : 339112 SIC : 3845
229 Avenida Fabricante, San Clemente, CA, USA, 92672
Description
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Name Current Vs Industry Vs History
Cash-To-Debt 1.09
Equity-to-Asset 0.57
Debt-to-Equity 0.64
Debt-to-EBITDA 18.26
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.09
Distress
Grey
Safe
Beneish M-Score -3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.55
9-Day RSI 56.38
14-Day RSI 55.15
6-1 Month Momentum % -9.22
12-1 Month Momentum % -46.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.84
Quick Ratio 8.39
Cash Ratio 7.47
Days Inventory 109.09
Days Sales Outstanding 44.17
Days Payable 42.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.2

Financials (Next Earnings Date:2022-08-05 Est.)

FRA:6GJ's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 254.592
EPS (TTM) (€) -0.52
Beta 0.95
Volatility % 57.26
14-Day RSI 55.15
14-Day ATR (€) 1.271716
20-Day SMA (€) 41.53
12-1 Month Momentum % -46.95
52-Week Range (€) 31.8 - 72.5
Shares Outstanding (Mil) 47.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Glaukos Corp Filings

Document Form Filing Date
No Filing Data